High mobility group box 1 (HMGB1), a protein widely distributed in the body, has been discovered to have the pro-inflammatory function and becomes in recent years one of the popular targets of research in critical care medicine, and NETs also seem to enhance the malignancy of cancer (28), for the possible reason, just like Zhang et al. This evidence concerns the gene HMGB1 and cancer.